Coming together to achieve quality cardiovascular care

Circulation

Volumn 113, Issue 5, 2006, Pages 607-608

  Douglas, Pamela S ^a,b   Eckel, Robert H ^c,d   Gray, Darryl T ^e   Loeb, Jerod M ^f   Straube, Barry M ^g  

^a AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c AMERICAN HEART ASSOCIATION   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^f DIVISION OF RESEARCH   (United States)

^g CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PERFORMANCE; EDITORIAL; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; COOPERATION; HUMAN; NOTE;

CARDIOVASCULAR DISEASES; COOPERATIVE BEHAVIOR; DELIVERY OF HEALTH CARE; HUMANS; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE;

EID: 33644851062     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.172861     Document Type: Editorial

References (8)

1. Marciniak TA, Mosedale L, Ellerbeck EF. Quality improvement at the national level. Lessons from the Cooperative Cardiovascular Project. Eval Health Prof. 1998;21:525-536.
2. Jencks SF, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA. 2000;284:1670-1676.
3. Jencks SF, Huff ED, Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. JAMA. 2003;289:305-312.
4. Spertus JA, Eagle KA, Krumholz HM, Mitchell KR, Normand SL. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005;45:1147-1156.
5. McClellan MB, Loeb JM, Clancy CM, et al. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure. Ann Intern Med. 2005;142:386-387.
6. Chen ZM, Pan HC, Chen YP, et al., COMMIT (ClOpidogrel and Metroprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1622-1632.
7. ACC/AHA/AHRQ/CMS/JCAHO Practice Advisory. Commitment to Respond to COMMIT/CCS-2 Trial Results: Beta-Blocker Use for Myocardial Infarction (MI) Within 24 Hours of Hospital Arrival. Available at: http://www.acc.org/clinical/ practice_advisory/pdfs/COMMITPracticeAdvisory040105.pdf. Accessed November 7, 2005.
8. Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation. 2006;113:732-761.